--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Gebelac: Güvenli Anne & Bebek" developer_entity: "Adem Emre Celik" bundle_id: "com.gebelikkategorisi" app_store_id: "1636219349" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS" app_last_updated: "2023-04-29" report_date: "2026-08-11" last_verified: "2026-08-11T00:00:00.000Z" report_version: "2.1.0" total_reviews: 0 confidence: "low" confidence_score: 0 data_age_days: 17 momentum_velocity: "zombie" intelligence_version: 3 tags: ["medical", "free", "mobile app", "app review", "app analysis", "healthcare", "professionals", "including"] canonical_url: "https://marlvel.ai/apps/gebelac-guvenli-anne-bebek" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Gebelac: Güvenli Anne & Bebek Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free > **TL;DR:** Gebelac: Güvenli Anne & Bebek is a medical app by Adem Emre Celik, available on iOS. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Gebelac: Güvenli Anne & Bebek is a medical app by Adem Emre Celik. ## Quick Facts | Fact | Value | | :--- | :--- | | **Category** | Medical | | **Developer** | Adem Emre Celik | | **Pricing** | Free | | **Platforms** | iOS | | **Confidence** | Low (0/1.0) | | **Data Age** | 17d | ## Metadata & Market Performance - **Publisher:** Adem Emre Celik - **Category:** Medical - **Target Audience:** Healthcare professionals including doctors, pharmacists, and nurses, as well as expectant and nursing mothers seeking safety information on medications. - **Platforms:** iOS - **Version Reviewed:** 2.1.0 - **Report Date:** 2026-08-11 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0/1.0) - **App Store ID (iOS):** 1636219349 - **Bundle ID:** com.gebelikkategorisi - **Performance Trend:** Declining - **Data Window:** Analysis based on signals collected up to 2026-08-11 ## Executive Snapshot **What it is:** Gebelac is a medical reference app for iOS that allows healthcare professionals and mothers to query the pregnancy and lactation risk status of medications. **Why users hire it:** Users hire Gebelac to quickly verify drug safety during pregnancy and breastfeeding, reducing the time required to consult clinical reference materials. ## App DNA (Features & Intent) - **[Standard] Pregnancy Risk Query:** Database lookup for drug active ingredients and herbal products to determine pregnancy risk categories. * *User Intent:* Users seek enhanced value through premium features. - **[Standard] Lactation Risk Query:** Database lookup for drug active ingredients and herbal products to determine safety during breastfeeding. * *User Intent:* Users seek enhanced value through premium features. ## Market Position {#market-position} Gebelac functions as a niche medical utility with no active chart presence, relying on its specialized database to serve a professional and patient audience. The 1,200-day update gap positions it as a legacy tool rather than a modern clinical resource. ## Monetization Strategy - **Model:** Free - **Tiers:** Free access to all search features - **Analysis:** The app operates as a free, ad-free utility with no visible monetization or subscription gates. ## SWOT Analysis {#swot} **Core Strengths:** - Specialized medical database provides immediate risk categorization for pregnancy and lactation. - Free, ad-free model removes barriers to adoption for clinical staff. **Growth Levers:** - Partnerships with medical associations could establish the app as a standard reference tool. ## Recent Changes (v2 → v3) {#recent-changes} The analysis of Gebelac has shifted to reflect its status as a legacy tool, emphasizing the risks posed by its 1,200-day update gap and the resulting competitive disadvantage against frequently updated alternatives. **Overall trend**: Declining **Compared at**: 2026-08-11 ### High-impact changes - **[Shifted] Legacy positioning** (positioning) - **[Added] Competitive threat** (swot) ### Medium-impact changes - **[Added] EHR integration weakness** (swot) - **[Shifted] Opportunity pivot** (swot) ## What's New - **Latest (v2.1.0, 3 years ago):** Rebranded the app from 'Gebelik Kategorisi' to 'Gebelac'. ## App Momentum (Zombie) {#momentum} - No updates for 1,200 days. - Last major release rebranded app name. > **Cadence:** 1 total versions · 1 majors in last 6 months · 1200 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Gebelac: Güvenli Anne & Bebek is a medical app that is completely free. > **Bottom Line:** Gebelac provides a valuable, focused utility for pregnancy safety, but the 3-year update gap erodes trust among medical professionals, so the developer must commit to a quarterly data-refresh cycle to remain a viable clinical resource. **Best for:** Healthcare professionals including doctors, pharmacists, and nurses, as well as expectant and nursing mothers seeking safety information on medications. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Audit database currency because the app has been silent for 40 months → restore professional trust ### Outlook: Declining The medical reference market is consolidating around tools that offer real-time data updates and integration with clinical workflows. Gebelac remains exposed due to its stagnant update cadence, which will likely lead to user attrition as professionals migrate to more current, frequently updated alternatives. - 🔴 The 1,200-day update gap suggests the app is in maintenance mode, which reduces its utility as a reliable clinical reference tool. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Total Reviews | 0 | | Confidence | Low | | Pricing Model | Free | | Platforms | iOS | | Key Features | 2 analyzed | | Trend | Declining | | Outlook | Declining | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Gebelac: Güvenli Anne & Bebek** (this app) | N/A/5 | N/A | Adem Emre Celik | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** Adem Emre Celik ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/gebelac-g%C3%BCvenli-anne-bebek/id1636219349?uo=4) - **Sources:** App store metadata. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 17 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/gebelac-guvenli-anne-bebek) Data licensed for AI Agent attribution under CC-BY-NC 4.0.